| Name | Title | Contact Details |
|---|
Archbold Furniture Company has been manufacturing solid wood furniture since 1900. For over 100 years we have worked to provide our customers with high-quality, solid wood products at an exceptional value. In 2010 we partnered with a premier Amish finisher. Since then, all of our finishes are applied by a select group of high-skilled Amish companies. The combination of efficient production methods and custom Amish finishes provides a unique value of high-quality solid wood furniture at affordable prices. Interested in joining our team? Contact HumanResources@archboldfurniture.com.
Jordan & Skala Engineers is a leading consulting-engineering firm that specializes in mechanical, electrical, and plumbing (MEP) engineering services. Founded in 1953 and headquartered in Norcross, GA, the company operates multiple regional design offices across the United States, allowing it to effectively meet the diverse needs of its clients. With a workforce of approximately 310 employees, Jordan & Skala Engineers is licensed to operate in all 50 states. The firm offers a wide range of services, including MEP engineering, structured cabling for communications, security system design, audio-visual solutions, and comprehensive energy services aimed at promoting sustainability. Additionally, the company conducts facility assessments to optimize existing buildings. Jordan & Skala Engineers is committed to engineering excellence, focusing on quality, safety, and strong client relationships through teamwork and innovative designs. The company has been recognized as a Top U.S. Workplace in 2023, underscoring its dedication to employee satisfaction and industry leadership.
Aim Sky High Academy is a Forbes featured, award-winning dance organisation featured in Forbes and Business Insider that aims to socially mobilise children and young people by teaching lifelong transferable skills through dance. Our students are current UK Hip Hop Dance Champions and have been used by Justin Bieber, Stormzy, Giggs and more. Awards won include: - Lloyds Bank School for Social Entrepreneurs Scale-Up Award 2016 - Social Enterprise UK Inspiring Youth Award 2015 - UDO World Champions 2014 - UDO European Champions 2014/15/16/19 - Barclays School for Start Ups Social Enterprise Winner 2013 ...and more. Come and follow our journey!
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.